Last reviewed · How we verify

NCT06140264

Effect of Acupuncture Dry Needle in Treatment of Chronic Mechanical Low Back Pain

Completed NA Last updated 15 February 2024
What this trial tests

NA trial testing Acupuncture dry needle in Low Back Pain in 30 participants. Completed in 21 February 2023.

Timeline
1 September 2022
Primary endpoint
11 January 2023
21 February 2023

Quick facts

Lead sponsorPrince Sattam Bin Abdulaziz University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date1 September 2022
Primary completion11 January 2023
Estimated completion21 February 2023
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Prince Sattam Bin Abdulaziz University

Who can join

Adults 20 to 45, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low back pain affects about 60% to 90% of the working-age population in modern industrial society. Chronic mechanical low back pain (CMLBP) is the most common problem of the working-age population in modern industrial society; it causes a substantial economic burden due to the wide use of medical services and absence from work. The purpose of this trial was to evaluate the short-term effect of acupuncture dry needle in treatment of chronic mechanical low back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Prince Sattam Bin Abdulaziz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06140264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing